GUENEVERE LINDGREN: Open Payments
NPI 1144545203 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 11 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $34 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 3 | $67 |
| ABBVIE INC. | 3 | $54 |
| Amgen Inc. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: Cologuard Collection Kit, UBRELVY, Qelbree, Dexcom G6 Transmitter, QULIPTA, AIRSUPRA, REPATHA, OTEZLA.
Industry payments across TX — which companies pay providers there.
